Physician profile
Bennett W Cheney
NPI 1083676548
$2,343.36
in general payments reported to CMS, 2019-2025
40 companies · $365 in 2025
The $365 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $417 · 2020: $348 · 2021: $119 · 2022: $317 · 2023: $450 · 2024: $328 · 2025: $365.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,143.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,142.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $203.83 | 2019-2024 | Breztri, Farxiga |
| Merck Sharp & Dohme LLC | $186.66 | 2019-2025 | Capvaxive, Gardasil 9, Gardasil |
| Bayer Healthcare Pharmaceuticals INC. | $163.42 | 2022-2025 | |
| Pfizer INC. | $160.63 | 2019-2024 | |
| Abbvie INC. | $149.49 | 2021-2025 | Vraylar, Ubrelvy |
| Amgen INC. | $136.07 | 2019-2025 | Evenity, Repatha, Otezla |
| Otsuka America Pharmaceutical, INC. | $117.83 | 2023-2025 | Rexulti |
| Glaxosmithkline, LLC. | $107.86 | 2020-2023 | Shingrix, Arexvy, Trelegy Ellipta |
| Radius Health, INC. | $90.55 | 2019-2021 | |
| Abbott Laboratories | $82.02 | 2023-2024 | Freestyle Libre 3, Freestyle Libre 2 |
| Novo Nordisk INC | $77.56 | 2019-2025 | Wegovy |
| Lilly USA, LLC | $66.78 | 2019-2025 | Jardiance, Kisunla, Zepbound |
| Astellas Pharma US INC | $62.75 | 2019-2024 | Veozah |
| Mannkind Corporation | $59.40 | 2022 | |
| Janssen Pharmaceuticals, INC | $55.17 | 2019-2022 |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bennett Cheney listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.